LUXOTTICA RETAIL NORTH AMERICA INC
230 N NELLIS BLVD, LAS VEGAS, NV 89110
NPI Number
1861593972
Practice location · View on Google Maps
SOS Verification: Pending Review
Multiple SOS Matches
Total Medicaid Payments
$471,447
+123% vs specialty average
Patients Seen
8,937
Total Claims
8,951
$ Per Patient
$53
Specialty avg: $21
Specialty Rank
#2 of 24
Eyewear Supplier (Equipment, not the service) providers in Nevada
Peer Average
$211,460
Average total for Eyewear Supplier (Equipment, not the service)
Claims per Patient
1.0
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2022 | $212,282 | |
| 2023 | $189,703 | |
| 2024 | $69,461 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| V2020 | Frames, purchases | 2,877 | $298,076 | 63.2% | $104 |
| 92340 | Eye exam or vision test | 2,306 | $72,455 | 15.4% | $31 |
| 92015 | Eye exam or vision test | 1,724 | $25,860 | 5.5% | $15 |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 578 | $25,432 | 5.4% | $44 |
| 92014 | Eye exam or vision test | 391 | $23,460 | 5.0% | $60 |
| 92004 | Eye exam or vision test | 233 | $13,980 | 3.0% | $60 |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 786 | $8,600 | 1.8% | $11 |
| V2410 | Variable asphericity lens, single vision, full field, glass or plastic, per lens | 56 | $3,584 | 0.8% | $64 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.